Locations
Indianapolis, IN, USA
industry
Biotechnology · DeepTech · Health
Size
1 - 10 employees
Stage
Other
founded in
2014
Anagin is developing first-in-class novel targeted therapies for neuropsychiatric disorders, including PTSD, TBI, depression, and neurodegenerative diseases. Their mission focuses on addressing disrupted synaptic plasticity in the central nervous system, aiming to provide disease-modifying and curative therapies. With a strong emphasis on research and development, Anagin is positioned to make significant advancements in treating conditions that affect millions globally, particularly veterans and civilians suffering from PTSD. The company is backed by federal funding and has a dedicated team with extensive experience in medicinal chemistry and drug discovery.
Is this your company?
Something looks off?